We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
This document sets out the testing requirements to verify that COVID-19 Rapid Antigen Test (RAT) kits included in the Australian Register of Therapeutic Goods (ARTG) meet the analytical sensitivity requirements outlined in the World Health Organisation (WHO) Technical Specifications of an acceptable analytical sensitivity range of 100 – 1000 TCID50/mL.
Results from this testing verifies the ability of a test kit to report a reactive result on a dilution of viral stock with determined TCID50/mL concentrations.